The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Effects of medicinal plants on Alzheimer's disease and memory deficits
Open accessAbstract
Alzheimer's disease is an age-related neurodegenerative disorder characterized by memory deficits. Various studies have been carried out to find therapeutic approaches for Alzheimer's disease. However, the proper treatment option is still not available. There is no cure for Alzheimer's disease, but symptomatic treatment may improve the memory and other dementia related problems. Traditional medicine is practiced worldwide as memory enhancer since ancient times. Natural therapy including herbs and medicinal plants has been used in the treatment of memory deficits such as dementia, amnesia, as well as Alzheimer's disease since a long time. Medicinal plants have been used in different systems of medicine, particularly Unani system of medicines and exhibited their powerful roles in the management and cure of memory disorders. Most of herbs and plants have been chemically evaluated and their efficacy has also been proven in clinical trials. However, the underlying mechanisms of actions are still on the way. In this paper, we have reviewed the role of different medicinal plants that play an important role in the treatment of Alzheimer's disease and memory deficits using conventional herbal therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghribi, O. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15412 · Cited by 68
RetractedMemory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
Squire, L. R. (1992) · Psychological Review · doi:10.1037/0033-295x.99.2.195 · Cited by 5,376 · cited 2×
“The condition is mimicked by severe depression (Squire, 1992).”
BackgroundYang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · cited 1×
“Other genes such as apolipoprotein E (APOE) are considered to be a risk factor for AD (Kim et al., 2009).”
BackgroundEpidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · cited 2×
“(Avila et al., 2004), supporting the concept that progres-”
BackgroundHepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Current and future treatments for Alzheimer's disease
Yiannopoulou, K. G., & Papageorgiou, S. G. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612461679 · Cited by 677 · cited 1×
“There is also a significant advancement in understanding the cholinesterase function in the brain and the use of cholinesterase inhibitors in management of AD (Wilkinson et al., 2004; Yiannopoulou and Papageorgiou, 2013).”
BackgroundThe effect of curcumin (turmeric) on Alzheimer’s disease: An overview
Mishra, S., & Palanivelu, K. (2008) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.40220 · Cited by 599
Lyte, M. (2011) · BioEssays · doi:10.1002/bies.201100024 · Cited by 549
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1
WANG, R., YAN, H., & TANG, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00255.x · Cited by 470
Bacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447
Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:
Grossberg, G. T. (2003) · Current Therapeutic Research · doi:10.1016/s0011-393x(03)00059-6 · Cited by 384
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339 · cited 1×
“Withania somnifera enhances dendrite and axon regeneration (Tomoharu et al., 2005).”
BackgroundChronic Effects of Brahmi (Bacopa monnieri) on Human Memory
Roodenrys, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00419-5 · Cited by 313 · cited 2×
“, 2015), Bacopa monnieri (Roodenrys et al., 2002), Desmodium gangeticum (Mahajan et al.”
BackgroundCalabrese, C., Gregory, W. L., Leo, M., Kraemer, D., Bone, K., & Oken, B. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0018 · Cited by 301
Neuropharmacological Review of the Nootropic Herb Bacopa monnieri
Aguiar, S., & Borowski, T. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1431 · Cited by 295
Cognitive enhancement and neuroprotective effects of Bacopa monnieri in alzheimer’s disease model
Uabundit, N., Wattanathorn, J., Mucimapura, S., & Ingkaninan, K. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.056 · Cited by 282
TOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272
Veerendra Kumar, M., & Gupta, Y. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03842.x · Cited by 249 · cited 2×
“The maximum response was observed after administration of extract at the doses of 200 and 300 mg/kg. Results from Veerendra and Gupta (2003) showed that Centella asiatica is effective in STZ-induced cognitive impairment in rats.”
BackgroundNardostachys jatamansi Improves Learning and Memory in Mice
Joshi, H., & Parle, M. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.113 · Cited by 136 · cited 1×
“Nardostachys jatamansi also reversed aging induced amnesia (Joshi and Parle, 2006).”
BackgroundAntioxidant property of Celastrus paniculatus Willd.: A possible mechanism in enhancing cognition
Kumar, M. H. V., & Gupta, Y. K. (2002) · Phytomedicine · doi:10.1078/0944-7113-00136 · Cited by 133
Honokiol is a potent scavenger of superoxide and peroxyl radicals
Dikalov, S., Losik, T., & Arbiser, J. L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.012 · Cited by 125 · cited 1×
“Honokiol exhibits anti-inflammatory activity by inhibiting reactive oxygen species synthesis (Dikalov et al., 2008).”
BackgroundNootropic activity of Celastrus paniculatus seed
Bhanumathy, M., Harish, M. S., Shivaprasad, H. N., & Sushma, G. (2010) · Pharmaceutical Biology · doi:10.3109/13880200903127391 · Cited by 88 · cited 1×
“Celastrus paniculatus increases cholinergic activity that contributes its ability to improving memory performance (Bhanumathy et al., 2010).”
BackgroundNahata, A., Patil, U. K., & Dixit, V. K. (2008) · Natural Product Research · doi:10.1080/14786410802214199 · Cited by 74 · cited 1×
“The ethanolic extract of Convolvulus pluricaulis and its aqueous and ethyl acetate fractions significantly improved memory retention and learning abilities in rats (Nahata et al., 2008).”
BackgroundGodkar, P. B., Gordon, R. K., Ravindran, A., & Doctor, B. P. (2006) · Phytomedicine · doi:10.1016/j.phymed.2003.11.011 · Cited by 72
Godkar, P., Gordon, R. K., Ravindran, A., & Doctor, B. P. (2003) · Fitoterapia · doi:10.1016/s0367-326x(03)00190-4 · Cited by 32 · cited 1×
“Administration of Celastrus paniculatus prevents neuronal cell damage caused by glutamine induced toxicity (Godkar et al., 2003).”
BackgroundAntiamnesic Activity of Extracts and Fraction of Desmodium Gangeticum
Department of Pharmaceutical Sciences and Drug Research, P. U., Mahajan, K., Kumar, D., Department of Pharmaceutical Sciences and Drug Research, P. U., Kumar, S., & Department of Pharmaceutical Sciences and Drug Research, P. U. (2015) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2015.31006 · Cited by 11
Cited by
Wahab, S., Annadurai, S., Abullais, S. S., Das, G., Ahmad, W., Ahmad, M. F., Kandasamy, G., Vasudevan, R., Ali, M. S., & Amir, M. (2021) · Plants · doi:10.3390/plants10122751 · Cited by 402
Neuroprotective Natural Products for Alzheimer’s Disease
Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236
Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
Miculas, D. C., Negru, P. A., Bungau, S. G., Behl, T., Hassan, S. S. U., & Tit, D. M. (2022) · Cells · doi:10.3390/cells12010131 · Cited by 96
Phytotherapy: A promising approach for the treatment of Alzheimer's disease
John, O. O., Amarachi, I. S., Chinazom, A. P., Adaeze, E., Kale, M. B., Umare, M. D., & Upaganlawar, A. B. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100030 · Cited by 69
Sun, X.-H., Dong, Y.-X., Zhang, H.-Y., Li, H.-Y., Liu, P.-H., & Sui, Y. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.232486 · Cited by 67
Metadata
- Authors
- Akram, M., & Nawaz, A.
- Venue
- Neural Regeneration Research
- Publisher
- Medknow
- Published
- 2017
- Volume
- 12
- Issue
- 4
- Pages
- 660
- ISSN
- 1673-5374 (ISSN-L)
- OpenAlex
- W2608044476
- Cited by
- 176
- References
- 29
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.